Renaissance Technologies’s Direxion Daily S&P Biotech Bull 3X ETF LABU Stock Holding History

Renaissance Technologies’s Portfolio LABU Stock Details LABU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	–	Sell	-22,900	Closed	-$3.65M	–	3495
2025 Q4	$3.65M	Buy	22,900 +2,200	+11%	+$302K	0.01%	1511
2025 Q3	$1.94M	Sell	20,700 -5,200	-20%	-$367K	﹤0.01%	2097
2025 Q2	$1.47M	Buy	+25,900	New	+$1.37M	﹤0.01%	2298
2024 Q1	–	Sell	-4,400	Closed	-$537K	–	3908
2023 Q4	$537K	Buy	+4,400	New	+$337K	﹤0.01%	2742
2022 Q2	–	Sell	-9,100	Closed	-$2.85M	–	4421
2022 Q1	$2.85M	Buy	+9,100	New	+$3.43M	﹤0.01%	1961

Other funds holding LABU

Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

Jump Financial Chicago, Illinois $12.4B AUM 62.79% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return

MIG

McGuire Investment Group Wakefield, Rhode Island $1.14B AUM 79.59% 1-Year Est. Return

Belvedere Trading Chicago, Illinois $87.6B AUM 131.08% 1-Year Est. Return

Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return

TSS

Two Sigma Securities New York $1.16B AUM 36.23% 1-Year Est. Return

Renaissance Technologies's LABU Position: Q1 2026 in Review

Renaissance Technologies sold out of Direxion Daily S&P Biotech Bull 3X ETF (LABU) in Q1 2026, closing a stake of 22,900 shares — an estimated $3.65M sold.

Renaissance Technologies first reported a position in LABU in Q1 2022 and held it in 5 quarters. The position peaked at $3.65M in Q4 2025. 33 funds tracked by Wall St. Rank hold LABU as of Q1 2026.

Renaissance Technologies reported no remaining Direxion Daily S&P Biotech Bull 3X ETF position as of Q1 2026 after selling out during the quarter.
Renaissance Technologies sold 22,900 Direxion Daily S&P Biotech Bull 3X ETF shares in Q1 2026, an estimated $3.65M.
Renaissance Technologies first reported a position in Direxion Daily S&P Biotech Bull 3X ETF in Q1 2022 and held it in 5 quarters.
Renaissance Technologies's Direxion Daily S&P Biotech Bull 3X ETF position peaked at $3.65M in Q4 2025.
33 funds tracked by Wall St. Rank held Direxion Daily S&P Biotech Bull 3X ETF as of Q1 2026.

Based on Renaissance Technologies's 13F filing for Q1 2026, filed 14 May 2026.